Geroa Diagnostics is a biotechnological company whose mission is to improve the health, the life-quality and medical care of patients suffering from Alzheimer’s disease. We accomplish this mission by developing innovative technologies and tools and by discovering new biomarkers for the diagnosis and early prediction of Alzheimer´s Disease as well as for exploring new therapeutic strategies for this and other CNS diseases.
Founded in 2015, Geroa Diagnostics is formed by Eva Carro and Gorka Orive, two internationally known scientists and by Juan Carlos del Castillo, an international expert in managing and leading innovative private companies in virtually all fields of biotechnology. Our novel proprietary scientific biomarker addresses numerous unmet needs in Alzheimer’s disease and has the potential to positively impact patients’ lives as well as those of their families.
Geroa Diagnostics is a Basque company that received funding from the SPRI (Business development Agency from the Basque Government, Vitoria, Spain)